Table 1. The inhibitory activity of compounds 2–11 with LdtMt2.
Compound | IC50 (μM, mean ± SD) |
|||
0 min a | 10 min | 60 min | ||
2 | Iodoacetamide | 129 ± 14 | 32.5 ± 1.4 | 10.1 ± 0.7 |
3 | Maleimide | 158 ± 9 | 48.3 ± 3.6 | 18.6 ± 0.7 |
4 | Ebselen | 0.36 ± 0.02 | 0.159 ± 0.077 | 0.143 ± 0.014 |
5 | PhSeBr | 11.8 ± 1.3 | 5.05 ± 0.35 | 2.02 ± 0.61 |
6 | PhSeCl | 62.8 ± 2.2 | 24.6 ± 0.9 | 20.0 ± 1.2 |
7 | PhSe(O)OH | 309 ± 7 | 136 ± 17 | 93.2 ± 9.3 |
8 | Thiram | 7.01 ± 0.29 | 2.93 ± 0.11 | 0.780 ± 0.029 |
9 | Aldrithiol | 22.1 ± 0.7 | 5.35 ± 0.21 | 1.61 ± 0.03 |
10 | PX-12 | 27.2 ± 0.5 | 9.56 ± 0.25 | 2.48 ± 0.10 |
11 | Faropenem | 1.69 ± 0.17 | 1.00 ± 0.04 | 0.686 ± 0.069 |
aThe impact of inhibitors on LdtMt2 was tested without pre-incubation, or with 10 min or 60 min pre-incubation prior to addition of fluorogenic probe 1.